EMT is important in cancer progression and metastasis and several studies have shown that EMT is disrupted following inhibition of PI3K/AKT/mTOR, although the exact mechanism by which mTOR signaling directly modulates EMT is not clear across all pathologic processes [199,200,201,202]. Here, MTOR is linked to cancer.